Literature DB >> 709848

Creatine kinase isoenzyme of high relative molecular mass in serum of a cancer patient.

H Yuu, Y Takagi, O Senju, J Hosoya, K Gomi, T Ishii.   

Abstract

We describe an atypical serum creatine kinase isoenzyme in the serum of a woman with cancer of the left breast. This isoenzyme migrated toward the cathode, closely following the MM isoenzyme on agarose gel electrophoresis. Its relative molecular mass was estimated to be about 325,000, fourfold that of normal creatine kinase. It is more heat-stable and is inhibited more by urea than the normal MM isoenzyme. Isoenzyme monomer B activity was observed to be 20 U/liter in the serum, as measured with use of an antibody against the M monomer. On anion-exchange column analysis, creatine kinase activity was observed only in the MM fraction, in spite of the fact that B activity was observed in the patient's serum. Results of the immunological investigation make it unlikely that the atypical isoenzyme is linked to immunoglobulin or beta-lipoprotein. It may have been present as the result of modification of normal creatine kinase by the therapeutic radiation the patient was receiving.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 709848

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  [Macro-creatine kinase; circulating immunoglobulin enzyme complexes as cause of elevated CK-activities (author's transl)].

Authors:  W Stein; J Bohner
Journal:  Klin Wochenschr       Date:  1979-10-15

2.  Total CK activity and isoenzyme patterns in normal and neoplastic tissue of gastrointestinal tract.

Authors:  S H Tsung
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

3.  Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer.

Authors:  P R Huber; T Zaugg; E Linder; V Hagmaier; G Rutishauser
Journal:  Urol Res       Date:  1982

4.  [Variant creatine kinase isoenzymes: frequency and clinical significance (author's transl)].

Authors:  P M Bayer; G Wider; W Unger; H Köhn; P Hajdusich; H Hotschek
Journal:  Klin Wochenschr       Date:  1982-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.